Drugs.com

JUNE 1, 2024

SATURDAY, June 1, 2024 -- Can mindfulness meditation be good medicine for both mental and physical ills? Yes, says one expert who explains the practice and what conditions it might help. A particular form of mindfulness that focuses on pleasure.

93

93

Drug Patent Watch

JUNE 1, 2024

Brivaracetam is the generic ingredient in two branded drugs marketed by Ucb Inc, Aurobindo Pharma Ltd, Lupin Ltd, Sunshine, and Zydus Pharms and, and is included in seven NDAs.

Drugs 59

Drugs Marketing 59

Perficient: Drug Development

JUNE 1, 2024

Permission sets in Salesforce are a powerful tool for granting users access to specific objects, fields, and functionality without modifying their profiles. However, testing permission sets is crucial to ensure they are working as intended and not causing any unintended consequences. Let’s discuss when and how to test permission sets, as well as some advanced techniques for more thorough testing. 1.

Licensing 59

Licensing Licensing Production 59

Drug Patent Watch

JUNE 1, 2024

Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five… Source

Drugs 59

Drugs Marketing 59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

Perficient: Drug Development

JUNE 1, 2024

As a Salesforce Admin, delivering projects on time and ensuring user adoption is crucial. However, one of the biggest challenges is getting User Acceptance Testing (UAT) right. Ineffective UAT can lead to costly delays, frustrated users, and even failed deployments. By focusing on these key areas, you can create a comprehensive UAT plan that validates the application from the end-user perspective and ensures it meets business requirements before going live.

Marketing 52

Marketing 52

Drug Patent Watch

JUNE 1, 2024

Annual Drug Patent Expirations for NUZYRA Nuzyra is a drug marketed by Paratek Pharms Inc and is included in two NDAs. It is available from one supplier.

Drugs 59

Drugs Marketing 59